Xin Lang Cai Jing·2026-03-27 06:53Company Overview - Tiger Med, established on December 15, 2004, and listed on August 17, 2012, is located in Hangzhou, Zhejiang Province. The company specializes in providing professional clinical research services for domestic and international pharmaceutical and health-related products. Its business scope includes I to IV phase clinical trial technical services, data management and statistical analysis, registration application, clinical trial site services, SMO services, medical testing services, medical documentation translation, medical imaging diagnosis services, and training services [1][6]. Financial Performance - As of March 27, Tiger Med's stock price increased by 5%, reaching 53.32 CNY per share, with a trading volume of 696 million CNY and a turnover rate of 2.35%. The total market capitalization is 45.91 billion CNY. The stock has seen a cumulative increase of 6.82% over the past three days [1][6]. Fund Holdings - Five funds under Tianhong Fund have significant holdings in Tiger Med, totaling 4.8279 million shares. Based on the previous day's closing price of 50.78 CNY and the current price of 53.32 CNY, the daily floating profit amounts to approximately 12.26 million CNY, with a total floating profit of 15.64 million CNY over the past three days [2][7]. Fund Details - The Tianhong Guozheng Biopharmaceutical ETF (159859) increased its holdings by 712,300 shares in the fourth quarter, now holding 3.35484 million shares, which constitutes 5.69% of the fund's net value, making it the fourth-largest holding. The estimated floating profit today is about 8.52 million CNY, with a total of 10.87 million CNY over the past three days [3][8]. - Tianhong Medical Innovation A (010654) reduced its holdings by 252,900 shares in the fourth quarter, currently holding 1.154923 million shares, representing 4.94% of the fund's net value, ranking as the ninth-largest holding. The estimated floating profit today is approximately 293.35 thousand CNY, with a total of 374.2 thousand CNY over the past three days [4][9]. - Tianhong Zhongzheng Medical 100 A (001550) holds 269,252 shares, accounting for 1.12% of the fund's net value, ranking as the second-largest holding. The estimated floating profit today is about 68.39 thousand CNY, with a total of 87.24 thousand CNY over the past three days [4][9].